For more than 100 years antibiotics have saved countless lives all over the world from infections that previously resulted in…
Read MoreSector: Medical
Filter By
Shanks v Unilever: “Outstanding Benefits” for both employer and employee
After a 13 year legal battle – in which the inventor lost every previous round – the Supreme Court has…
Read MoreInspirational and innovative: the medical devices of tomorrow
Companies working in the medical device space are an inspiration, working tirelessly to improve the lives of patients and their…
Read MoreHair-raising developments in medical materials
Tailoring the properties exhibited by a material has classically focussed on altering its chemical or compositional nature (for example, to…
Read MorePlausibility at the EPO – how much data or experimental information is enough?
A patent for an invention provides its owner with the right to exclude others from making, using, offering for sale…
Read MoreSufficiency vs. reward – the fundamental balance underpinning the patent system
The patent system operates on the basis of a simple premise—to encourage innovators to share the secrets of their new,…
Read MoreMy star inventor is leaving to work with a competitor. What can I do?
It’s the letter no employer wants to receive: a key employee resigning to move to a rival company. But it…
Read MoreSmall but mighty: Medical device technology punching above its weight
From tongue depressors to MRI machines to pace makers, the range of medical devices sold is vast. Today, the development…
Read MoreDon’t let your IP go up in smoke…
The legalisation of cannabis is a hot topic. Some of the major US states have already, or will soon be,…
Read MoreYour iPhone will see you now
What were the final items you picked up before leaving home this morning? Chances are that it was your keys….
Read MorePatently obvious: how to get the most out of your invention
This article was previously published in Med-Tech Innovation News March/April 2018 edition. 1. Where do you start in planning for…
Read MoreA Blow to Broad Antibody-to-Target Claims – The USPTO Follows Amgen Inc. v. Sanofi (Fed. Cir. 2017) and Issues New Guidance
Upon discovery of a novel biological target, for example in a newly characterised pathway, it is fairly common to attempt…
Read More